To validate the relationship between PRSS23 and ERα expression, we selected 6 representative sets of tumor samples from breast cancer patients that were either ERα-positive (Fig. 2A, B, C) or ERα-negative (Fig. 2D, E, F). This evidence concerns the gene PRSS23 and neoplasm.